-
Opicapone, sold
under the
brand name Ongentys, is a
medication which is
administered together with
levodopa in
people with Parkinson's disease. Opicapone...
- the
development and
commercialization of the Parkinson's
disease drug,
opicapone, in
North America with the Portugal-based
pharmaceutical company Bial...
- Stalevo)
Opicapone (Ongentys)
Tolcapone (Tasmar) Not
marketed Nebicapone (BIA 3-202)
Neluxicapone Nitecapone (OR-462)
Entacapone and
opicapone are peripherally...
- in
peripheral sympathetically innervated tissues,
without CNS effects.
Opicapone (BIA 9-1067), Bial's
second pharmaceutical, is a COMT
inhibitor for the...
-
capable of
decreasing 3-O-methyldopa, like entacapone,
tolcapone and
opicapone (COMT inhibitors), when
administered in
combination with L-DOPA, lead...
-
inhibitors such as entacapone,
opicapone, and tolcapone,
which are used in the
treatment of Parkinson's disease.
Entacapone and
opicapone are
peripherally selective...
- 4-Hydroxyestrone→4-Methoxyestrone Inhibitors: 2-Hydroxyestradiol 2-Hydroxyestrone
Entacapone Nebicapone Neluxicapone Nitecapone Opicapone Quinalizarin Tolcapone...
-
patent application describes a
synthetic route for the
active ingredient opicapone,
which has been
approved in the EU
since 2016, in
which 5-nitrovanilline...
-
serotonin 5-HT3
receptor antagonist with some
peripheral selectivity Opicapone – a catechol-O-methyltransferase
inhibitor used in
combination with levodopa...
-
Safinamide N04BX01
Tolcapone N04BX02
Entacapone N04BX03
Budipine N04BX04
Opicapone N04CX01
Istradefylline "ATC (Anatomical
Therapeutic Chemical classification...
